Coya Therapeutics Inc (COYA)

Jan 29, 2025

(COYA) Long Term Investment Analysis - Stock Traders Daily

Jan 29, 2025

Jan 27, 2025

An ALS treatment wave is approaching, and this biotech CEO is ready to surf - PharmaVoice

Jan 27, 2025

Jan 22, 2025

Coya Therapeutics advances COYA 303 for inflammatory diseases By Investing.com - Investing.com Australia

Jan 22, 2025

Jan 22, 2025

Coya Therapeutics (NASDAQ:COYA) Given “Buy” Rating at D. Boral Capital - Defense World

Jan 22, 2025

Jan 21, 2025

Coya Therapeutics' (COYA) "Buy" Rating Reaffirmed at D. Boral Capital - MarketBeat

Jan 21, 2025

Jan 21, 2025

EXCLUSIVE: Coya Therapeutics Expands Its Pipeline With Combo Therapy For Inflammatory Diseases - AOL

Jan 21, 2025

Jan 21, 2025

Coya Therapeutics advances COYA 303 for inflammatory diseases - Investing.com India

Jan 21, 2025

Jan 21, 2025

Coya Therapeutics Unveils COYA 303: Novel GLP-1 Combination Therapy for Inflammatory Diseases - StockTitan

Jan 21, 2025

Jan 20, 2025

Coya Therapeutics, Inc. (NASDAQ:COYA) Short Interest Up 10.2% in December - MarketBeat

Jan 20, 2025

Jan 15, 2025

Revolutionizing Success in the AI in Clinical Trials Market: - openPR

Jan 15, 2025

Jan 11, 2025

Geode Capital Management LLC Has $918,000 Stake in Coya Therapeutics, Inc. (NASDAQ:COYA) - Defense World

Jan 11, 2025

Jan 08, 2025

How to Take Advantage of moves in (COYA) - Stock Traders Daily

Jan 08, 2025

Dec 18, 2024

Coya Therapeutics (NASDAQ:COYA) Receives "Buy" Rating from D. Boral Capital - MarketBeat

Dec 18, 2024

Dec 18, 2024

Coya Therapeutics enrolls five in FTD study, eyes Phase 2 trial - Investing.com

Dec 18, 2024

Dec 18, 2024

Objective long/short (COYA) Report - Stock Traders Daily

Dec 18, 2024

Dec 16, 2024

Regulatory T-cells (Tregs) Therapies Market Key Players - openPR

Dec 16, 2024

Dec 10, 2024

Factors Influencing Global Regulatory T Cell Tregs Therapies - openPR

Dec 10, 2024

Dec 06, 2024

Exosome Therapeutics Market Applications in Neurological - openPR

Dec 06, 2024

Dec 04, 2024

Boral Capital initiates coverage on Coya Therapeutics with Buy rating By Investing.com - Investing.com Canada

Dec 04, 2024

Dec 04, 2024

Coya Therapeutics (NASDAQ:COYA) Now Covered by D. Boral Capital - MarketBeat

Dec 04, 2024

Dec 04, 2024

D. Boral Capital Initiates Coverage of Coya Therapeutics (COYA) with Buy Recommendation - MSN

Dec 04, 2024

Dec 02, 2024

INNOVATIONMAP EMAILS ARE AWESOME - InnovationMap

Dec 02, 2024

Nov 25, 2024

Coya Therapeutics to Participate in a Fireside Chat at the 7th Annual Evercore HealthCONx Conference - StockTitan

Nov 25, 2024

Nov 22, 2024

Alzheimer’s Disease Market Size to Reach US$ 6.3 Billion by 2034, Impelled by Advancements in Early Detection - IMARC Group

Nov 22, 2024

Nov 21, 2024

Coya Therapeutics files to sell 1.38M shares of common stock for holders - MSN

Nov 21, 2024

Nov 19, 2024

Coya Therapeutics sets sights on neurodegenerative trials in 2025 - Investing.com India

Nov 19, 2024

Nov 19, 2024

Coya Therapeutics Advances $700M ALS Program, Sets Key 2025 Clinical Milestones | COYA Stock News - StockTitan

Nov 19, 2024

Nov 16, 2024

Trend Tracker for (COYA) - Stock Traders Daily

Nov 16, 2024

Nov 15, 2024

Insider Buying: CFO David Snyder Acquires Shares of Coya Therape - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Coya therapeutics CFO David Snyder buys $12,934 in stock - Investing.com

Nov 14, 2024

Nov 14, 2024

HC Wainwright Has Positive Forecast for COYA FY2024 Earnings - MarketBeat

Nov 14, 2024

Nov 13, 2024

Insider Buying: Coya Therapeutics Inc (COYA) Sees Purchase from Chief Medical Officer - GuruFocus.com

Nov 13, 2024

Nov 11, 2024

Coya Therapeutics (NASDAQ:COYA) Receives "Buy" Rating from HC Wainwright - MarketBeat

Nov 11, 2024

Nov 09, 2024

Coya Therapeutics (NASDAQ:COYA) Announces Earnings Results - MarketBeat

Nov 09, 2024

Nov 08, 2024

The Friday Biotech Perspective #32 - substack.com

Nov 08, 2024

Nov 07, 2024

Meet 5 of the fastest-growing scaleup companies in Houston - InnovationMap

Nov 07, 2024

Nov 07, 2024

Coya Therapeutics' (COYA) "Buy" Rating Reaffirmed at Chardan Capital - MarketBeat

Nov 07, 2024

Nov 07, 2024

Coya Therapeutics Reports Q3 2024 Highlights and Progress - TipRanks

Nov 07, 2024

Nov 06, 2024

Coya Therapeutics board member resigns due to new job policy By Investing.com - Investing.com Canada

Nov 06, 2024

Nov 06, 2024

Coya Therapeutics Advances Pipeline for Neurodegenerative Diseases - TipRanks

Nov 06, 2024

Nov 06, 2024

Coya Therapeutics Provides a Corporate Update and Reports Unaudited Third Quarter 2024 Financial Results - The Bakersfield Californian

Nov 06, 2024

Nov 06, 2024

Coya Therapeutics board member resigns due to new job policy - Investing.com India

Nov 06, 2024

Nov 05, 2024

Long Term Trading Analysis for (COYA) - Stock Traders Daily

Nov 05, 2024

Nov 05, 2024

Arun Swaminathan assumes new role as chief executive officer of Coya Therapeutics - pharmabiz.com

Nov 05, 2024

Nov 01, 2024

Coya Therapeutics appoints new CEO amid Alzheimer's trial progress By Investing.com - Investing.com South Africa

Nov 01, 2024

Nov 01, 2024

Coya Therapeutics, Inc. (NASDAQ:COYA) Sees Significant Increase in Short Interest - MarketBeat

Nov 01, 2024

Nov 01, 2024

Coya Therapeutics appoints new CEO amid Alzheimer's trial progress - Investing.com

Nov 01, 2024

Nov 01, 2024

Coya Therapeutics Promotes Arun Swaminathan, Ph.D. to Chief Executive Officer - citybiz

Nov 01, 2024

Nov 01, 2024

Coya Therapeutics Announces Arun Swaminathan, Ph.D. Assumes New Role as Chief Executive Officer - StockTitan

Nov 01, 2024

Oct 31, 2024

Coya Therapeutics announces executive changes - Investing.com India

Oct 31, 2024

Oct 31, 2024

Coya Therapeutics Announces Leadership Change and New CEO - TipRanks

Oct 31, 2024